Page 135 - Haematologica May 2022

GECPAR, eRNA master regulator of germinal center
49. Johannes JW, Almeida L, Barlaam B, et al. Pyrimidinone nicotinamide mimetics as selective tankyrase and wnt pathway inhibitors suitable for in vivo pharmacology. ACS Med Chem Lett. 2015;6(3):254-259.
50. Franco HL, Nagari A, Malladi VS, et al. Enhancer transcription reveals subtype-spe- cific gene expression programs controlling breast cancer pathogenesis. Genome Res. 2018;28(2):159-170.
51.Zhang Z, Lee JH, Ruan H, et al. Transcriptional landscape and clinical utility of enhancer RNAs for eRNA-targeted thera- py in cancer. Nat Commun. 2019;10(1): 4562.
52. Fagerberg L, Hallstrom BM, Oksvold P, et al. Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based pro- teomics. Mol Cell Proteomics. 2014;13(2):
397-406.
53.Leveille N, Melo CA, Rooijers K, et al.
Genome-wide profiling of p53-regulated enhancer RNAs uncovers a subset of enhancers controlled by a lncRNA. Nat Commun. 2015;6:6520.
54. Li X, Fu XD. Chromatin-associated RNAs as facilitators of functional genomic interac- tions. Nat Rev Genet. 2019;20(9):503-519.
55. Guttman M, Donaghey J, Carey BW, et al. lincRNAs act in the circuitry controlling pluripotency and differentiation. Nature. 2011;477(7364):295-300.
56. Pasqualucci L. Molecular pathogenesis of germinal center-derived B cell lymphomas. Immunol Rev. 2019;288(1):240-261.
57. Luo W, Weisel F, Shlomchik MJ. B cell recep- tor and CD40 signaling are rewired for syn- ergistic induction of the c-Myc transcription factor in germinal center B cells. Immunity.
2018;48(2):313-326.
58.Boi M, Zucca E, Inghirami G, et al.
PRDM1/BLIMP1: a tumor suppressor gene in B and T cell lymphomas. Leuk Lymphoma. 2015;56(5):1223-1228.
59. Tandon B, Peterson L, Gao J, et al. Nuclear overexpression of lymphoid-enhancer-bind- ing factor 1 identifies chronic lymphocytic leukemia/small lymphocytic lymphoma in small B-cell lymphomas. Mod Pathol. 2011;24(11):1433-1443.
60. Hao YH, Lafita-Navarro MC, Zacharias L, et al. Induction of LEF1 by MYC activates the WNT pathway and maintains cell prolifera- tion. Cell Commun Signal. 2019;17(1):129.
61. Bognar MK, Vincendeau M, Erdmann T, et al. Oncogenic CARMA1 couples NF-kappaB and beta-catenin signaling in diffuse large B- cell lymphomas. Oncogene. 2016;35(32): 4269-4281.
haematologica | 2022; 107(5)
1143